Author

Erin Schubert

Observed names: E Schubert, E.K. Schubert, Schubert, Erin

Institution: University of Pennsylvania

Observed institutions: University of Washington, University of Pennsylvania

ORCID: 0009-0001-9105-5829

Observed ORCID: 0009-0001-9105-5829

OpenAlex ID: A5066610065

FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

2024 · Thomas M. Anderson, Bryan H. Chang, et al. · Clinical Cancer Research · 19

Relationship of Ketosis With Myocardial Glucose Uptake Among Patients Undergoing FDG PET/CT for Evaluation of Cardiac Sarcoidosis

2024 · Mahesh K. Vidula, Senthil Selvaraj, et al. · Circulation Cardiovascular Imaging · 11

Brain-gut axis imaging, motion correction with [ 11 C]-carfentanil total-body PET

2026 · Elizabeth J Li, Sophie Lammers, et al. · medRxiv · 1

Supplementary Table S1 from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

2024 · Thomas M. Anderson, Bryan H. Chang, et al. · 1

456 FES PET is an Imaging Biomarker of Pharmacodynamic Response to Estrogen Receptor (ER) Modulating Therapies in Breast Cancer

2012 · K.A. Krohn, H.M. Linden, et al. · European Journal of Cancer · 1

DCE-MRI and dynamic FDG PET to monitor breast cancer response to neoadjuvant sunitinib in patients with locally-advanced breast cancer.

2009 · JM Specht, S Partridge, et al. · Cancer Research · 1

A phase 2 study of niraparib concomitant with tumor treating fields in patients with recurrent grade 4 glioma

2026 · Elizabeth C Cordell, Maikel Mansour, et al. · Neuro-Oncology Advances

Kinetic assessment of 18F-(2S,4R)4-fluoroglutamine alongside [18F]FDG PET in breast cancer patients to evaluate tumor metabolism

2026 · Damani, Raheema, Li, Elizabeth J, et al. · Ghent University Academic Bibliography (Ghent University)

Supplementary Table S2 from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

2024 · Thomas M. Anderson, Bryan H. Chang, et al.

Supplementary Table S3 from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

2024 · Thomas M. Anderson, Bryan H. Chang, et al.

Supplementary Figure S4 from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

2024 · Thomas M. Anderson, Bryan H. Chang, et al.

Supplementary Table S1 from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

2024 · Thomas M. Anderson, Bryan H. Chang, et al.

Supplementary Figure S3 from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

2024 · Thomas M. Anderson, Bryan H. Chang, et al.

Supplementary Table S2 from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

2024 · Thomas M. Anderson, Bryan H. Chang, et al.

Supplementary Figure S2 from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

2024 · Thomas M. Anderson, Bryan H. Chang, et al.

Supplementary Figure S5 from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

2024 · Thomas M. Anderson, Bryan H. Chang, et al.

Supplementary Figure S3 from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

2024 · Thomas M. Anderson, Bryan H. Chang, et al.

Supplementary Figure S5 from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

2024 · Thomas M. Anderson, Bryan H. Chang, et al.

Supplementary Figure S4 from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

2024 · Thomas M. Anderson, Bryan H. Chang, et al.

Supplementary Figure S2 from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

2024 · Thomas M. Anderson, Bryan H. Chang, et al.

Supplementary Figure S1 from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

2024 · Thomas M. Anderson, Bryan H. Chang, et al.

Supplementary Table S3 from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

2024 · Thomas M. Anderson, Bryan H. Chang, et al.

Supplementary Figure S1 from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

2024 · Thomas M. Anderson, Bryan H. Chang, et al.

Data from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

2024 · Thomas M. Anderson, Bryan H. Chang, et al.

Data from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

2024 · Thomas M. Anderson, Bryan H. Chang, et al.

Works count: 25

Citation count: 34

H-index: 2

I10-index: 2